Estimates Revisions BioRestorative Therapies, Inc.
Stocks
BRTX
US0906556065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3525 USD | -6.25% |
|
-12.96% | -70.00% |
| 05-27 | Kaos Capital acquires 4.9% stake in BioRestorative Therapies | RE |
| 05-26 | BioRestorative Completes Dosing in Phase 2 Trial of BRTX-100 to Treat Chronic Lumbar Disc Disease; Shares Rise | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- BRTX Stock
- Consensus BioRestorative Therapies, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
